![]() |
![]() |
Fast Track
![]() ![]() ![]() |
![]() |
|||||||||
| OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web |
|
Prostate Cancer |
Free Subscription
1 Anticancer Res |
Retrieve available abstracts of this week’s articles:
HTML format Text format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Cost-effectiveness of Multiparametric MRI in 800 Men Submitted to Repeat Prostate
Biopsy: Results of a Public Health Model.
Anticancer Res. 2018;38:2395-2398.
PubMed
Text format
Abstract available
Intermittent docetaxel therapy versus continuous docetaxel therapy in patients
with castration resistant prostate cancer (CRPC) - a phase III study (PRINCE).
BJU Int. 2018 Apr 10. doi: 10.1111/bju.14239.
PubMed
Text format
Abstract available
Guideline of guidelines: primary monotherapies for localised or locally advanced
prostate cancer.
BJU Int. 2018 Apr 7. doi: 10.1111/bju.14237.
PubMed
Text format
Abstract available
Does the introduction of prostate multiparametric MRI into active surveillance of
localised prostate cancer improve patient re-classification?
BJU Int. 2018 Apr 12. doi: 10.1111/bju.14248.
PubMed
Text format
Abstract available
Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent
growth and invasion in metastatic prostate cancer cells.
BMC Cancer. 2018;18:421.
PubMed
Text format
Abstract available
(18)F-NaF/(223)RaCl2 theranostics in metastatic prostate cancer: treatment
response assessment and prediction of outcome.
Br J Radiol. 2018 Apr 9:20170948. doi: 10.1259/bjr.20170948.
PubMed
Text format
Abstract available
Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone
via the VCAM-1/integrin alpha4beta1 system.
Cancer Lett. 2018 Apr 5. pii: S0304-3835(18)30254.
PubMed
Text format
Abstract available
Balloon pulmonary angioplasty in a patient with prostate cancer and chronic
thromboembolic pulmonary hypertension.
Clin Imaging. 2018;50:185-187.
PubMed
Text format
Abstract available
Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE
still needed?
Eur Radiol. 2018 Apr 9. pii: 10.1007/s00330-018-5352.
PubMed
Text format
Abstract available
Will Image-guided Metastasis-directed Therapy Change the Treatment Paradigm of
Oligorecurrent Prostate Cancer?
Eur Urol. 2018 Apr 3. pii: S0302-2838(18)30202.
PubMed
Text format
Re: Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Eur Urol. 2018 Apr 10. pii: S0302-2838(18)30247.
PubMed
Text format
Re: Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate
Cancer Active Surveillance Outcomes.
Eur Urol. 2018 Apr 9. pii: S0302-2838(18)30242.
PubMed
Text format
(99m)Technetium-based Prostate-specific Membrane Antigen-radioguided Surgery in
Recurrent Prostate Cancer.
Eur Urol. 2018 Apr 3. pii: S0302-2838(18)30189.
PubMed
Text format
Abstract available
Re: Focal Therapy in Primary Localised Prostate Cancer: The European Association
of Urology Position in 2018.
Eur Urol. 2018 Apr 3. pii: S0302-2838(18)30204.
PubMed
Text format
Editorial Comment to Prostate-specific antigen screening impacts on biochemical
recurrence in patients with clinically localized prostate cancer.
Int J Urol. 2018 Apr 12. doi: 10.1111/iju.13578.
PubMed
Text format
Editorial Comment to Influence of prior oral ethinylestradiol use on the efficacy
of enzalutamide for the treatment of castration-resistant prostate cancer in men.
Int J Urol. 2018 Apr 12. doi: 10.1111/iju.13572.
PubMed
Text format
Prostate-specific antigen screening impacts on biochemical recurrence in patients
with clinically localized prostate cancer.
Int J Urol. 2018 Apr 6. doi: 10.1111/iju.13563.
PubMed
Text format
Abstract available
Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed
to predict survival in node-positive prostate cancer patients: External
validation on a multi-institutional database.
Int J Urol. 2018 Apr 6. doi: 10.1111/iju.13565.
PubMed
Text format
Abstract available
Editorial Comment to Evaluating the predictive accuracy and the clinical benefit
of a nomogram aimed to predict survival in node-positive prostate cancer
patients: External validation on a multi-institutional database.
Int J Urol. 2018 Apr 12. doi: 10.1111/iju.13575.
PubMed
Text format
Role of bone scan index in the prognosis and effects of therapy on prostate
cancer with bone metastasis: Study design and rationale for the multicenter
Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan
Index (PROSTAT-BSI)
Int J Urol. 2018 Apr 6. doi: 10.1111/iju.13556.
PubMed
Text format
Abstract available
Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed
brachytherapy in patients with low- and intermediate-risk prostate cancer.
Int J Urol. 2018 Apr 12. doi: 10.1111/iju.13555.
PubMed
Text format
Abstract available
Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer.
J Clin Oncol. 2018 Apr 13:JCO2017766907. doi: 10.1200/JCO.2017.76.6907.
PubMed
Text format
Abstract available
Predictive factors of response and overall survival in patients with
castration-resistant metastatic prostate cancer undergoing (177)Lu-PSMA therapy.
J Nucl Med. 2018 Apr 13. pii: jnumed.118.209270. doi: 10.2967/jnumed.118.209270.
PubMed
Text format
Potential impact of (68)Ga-PSMA-11 PET/CT on prostate cancer definitive radiation
therapy planning.
J Nucl Med. 2018 Apr 13. pii: jnumed.118.209387. doi: 10.2967/jnumed.118.209387.
PubMed
Text format
Abstract available
Reproducibility and repeatability of semi-quantitative
(18)F-fluorodihydrotestosterone (FDHT) uptake metrics in castration-resistant
prostate cancer metastases: a prospective multi-center study.
J Nucl Med. 2018 Apr 6. pii: jnumed.117.206490. doi: 10.2967/jnumed.117.206490.
PubMed
Text format
Abstract available
(11)C-choline pharmacokinetics in recurrent prostate cancer.
J Nucl Med. 2018 Apr 6. pii: jnumed.118.210088. doi: 10.2967/jnumed.118.210088.
PubMed
Text format
Abstract available
Re: Health-Related Quality of Life for Immediate versus Delayed
Androgen-Deprivation Therapy in Patients with Asymptomatic, Non-Curable Prostate
Cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): A Randomised, Multicentre,
Non-Blinded, Phase 3 Trial.
J Urol. 2018;199:892-894.
PubMed
Text format
Re: Cabazitaxel versus Docetaxel as First-Line Therapy for Patients with
Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III
Trial-FIRSTANA.
J Urol. 2018;199:893-894.
PubMed
Text format
Re: Prostate Cancer-Associated SPOP Mutations Confer Resistance to BET Inhibitors
through Stabilization of BRD4.
J Urol. 2018;199:895-896.
PubMed
Text format
Re: Robotic Salvage Retroperitoneal and Pelvic Lymph Node Dissection for
'Node-Only' Recurrent Prostate Cancer: Technique and Initial Series.
J Urol. 2018;199:875-876.
PubMed
Text format
Re: Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status
and Future Challenges.
J Urol. 2018;199:873.
PubMed
Text format
The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on
Prostate-Specific Antigen and Radiographic Disease Progression in Patients with
Non-Metastatic Castration-Resistant Prostate Cancer.
J Urol. 2018 Apr 6. pii: S0022-5347(18)42900-X. doi: 10.1016/j.juro.2018.
PubMed
Text format
Abstract available
Prostate cancer and social media.
Nat Rev Urol. 2018 Apr 11. pii: 10.1038/s41585-018-0006.
PubMed
Text format
Abstract available
A case-control study of lower urinary-tract infections, associated antibiotics
and the risk of developing prostate cancer using PCBaSe 3.0.
PLoS One. 2018;13:e0195690.
PubMed
Text format
Abstract available
Indirect treatment comparison of cabazitaxel for patients with metastatic
castrate-resistant prostate cancer who have been previously treated with a
docetaxel-containing regimen.
PLoS One. 2018;13:e0195790.
PubMed
Text format
Abstract available
Comprehensive Geriatric Assessment and quality of life after localized prostate
cancer radiotherapy in elderly patients.
PLoS One. 2018;13:e0194173.
PubMed
Text format
Abstract available
Understanding of multigene test results among males undergoing germline testing
for inherited prostate cancer: Implications for genetic counseling.
Prostate. 2018 Apr 14. doi: 10.1002/pros.23535.
PubMed
Text format
Abstract available
Pharmacological upregulation of prostate-specific membrane antigen (PSMA)
expression in prostate cancer cells.
Prostate. 2018 Apr 6. doi: 10.1002/pros.23522.
PubMed
Text format
Abstract available
Earlier use of androgen receptor-axis-targeted drugs may improve overall survival
in patients with non-metastatic castration-resistant prostate cancer.
Prostate. 2018 Apr 10. doi: 10.1002/pros.23534.
PubMed
Text format
Abstract available
Impact of Accountable Care Organizations on Diagnostic Testing for Prostate
Cancer.
Urology. 2018 Apr 6. pii: S0090-4295(18)30300.
PubMed
Text format
Abstract available
The Influence of Ethnic Heterogeneity on Prostate Cancer Mortality after Radical
Prostatectomy in Hispanic/Latino Men: A Population-Based Analysis.
Urology. 2018 Apr 6. pii: S0090-4295(18)30293.
PubMed
Text format
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by